Jubilant Ingrevia expands Diketene Derivatives facility in UP
02 Apr 24 2 min read
Insights
- Jubilant Ingrevia Limited inaugurates new facility for Diketene derivatives in Uttar Pradesh.
- The addition of ~2,000 TPA capacity aims for accelerated growth and higher margins.
- Plans include expanding offerings to new international markets like the US and EU.
- CEO Deepak Jain underscores commitment to innovation with advanced product portfolio.
The newly commissioned facility adds additional capacity of ~2,000 TPA to produce high-value esters. This strengthening of the Diketene and derivatives platform marks a natural evolution of strategy in the Specialty Chemicals segment. This business is pivoting towards accelerated growth and higher margins with the introduction of several downstream derivatives.
In line with its long-term strategic objectives, Jubilant Ingrevia remains committed to commissioning of future phases of Diketene derivatives. In addition to existing clients the expanded range of diketene derivatives will be aimed at a new category of customers in key international markets, including the U.S and E.U regions.
On this occasion, Mr. Deepak Jain, chief executive officer and managing director, Jubilant Ingrevia Limited, said, “I am delighted to emphasise our unwavering dedication to specialty chemicals business with the introduction of this new facility. Diketene and derivatives represent an accelerated growth platform for us. We are committed to cultivating a comprehensive range of advanced product portfolio within this segment with about half a dozen existing derivatives and several new ones in pipeline. Today’s announcement marks an inflection in growth as this advancement will bring us closer to satisfying our client’s needs for innovative products and solutions, leveraging a distinctive and specialised chemistry platform”.
Whereas the existing range of offerings in diketene and derivatives has ramped up markedly, the next iteration of growth shall come from introduction of new products that are presently in the pipeline. The Company’s long-standing association with leading customers in pharmaceuticals, agrochemicals and other industries combined with early efforts to get customer product approvals, are expected to drive major portion of capacity utilisation in the coming months.
Note: The content of this press release has not been edited by Fibre2Fashion staff.
Fibre2Fashion News Desk (HU)
Popular News
|
Major global brands commit to decarbonise fashion sector |
|
EU Council set to begin talks on revision of waste framework directive |
|
ICE cotton hits 2-year lows, traders waiting to buy at low prices |
|
4th China & Asia Textile & Apparel Summit to be held in Shanghai |
|
US’ small business optimism reaches highest level of year in May: NFIB |
|
Poor demand of cotton yarn in south India, prices down in Mumbai |